In accordance with Lindsley et al. [4], all MR gene mutations, except for mutated ZRSR2, were more frequently observed in s-AML in the whole cohort, underlining their significance in the pathogenesis of s-AML. The gene discussed is NR3C2; the disease is acute myeloid leukemia.